Medical technology company, Semler Scientific, has expanded its Bitcoin holdings by acquiring 185 BTC for $20 million between May 23 and June 3, 2025. The average purchase price was $107,974 per BTC. Chairman Eric Semler shared the update on X on June 4.
Following a Controlled Equity Offering on April 15, 2025, with firms like Barclays and Cantor Fitzgerald, Semler raised $136.2 million by selling 3.54 million shares as of June 3, 2025. These funds are being actively used for Bitcoin accumulation.
4,449 BTC Achieved
The technology firm disclosed an average BTC acquisition price of $92,158, underscoring its calculated approach to Bitcoin investment. This strategic asset allocation positions the company as a major BTC holder outside the crypto space, aligning with other high-profile firms adopting similar treasury strategies to optimize their portfolios and capitalize on Bitcoin’s potential.
With 4,449 BTC on its balance sheet, the medical technology company’s holdings are worth $472.9 million, based on prices as of June 3, with an initial investment of $410 million.
Notably, Semler’s Bitcoin investment has yielded a 26.7% return year-to-date, demonstrating the cryptocurrency’s potential as a profitable treasury asset and validating its role in generating substantial returns.
This move reinforces the growing trend of corporate Bitcoin accumulation, echoing playbooks used by companies like Strategy and reflecting institutional investors’ confidence in Bitcoin’s long-term potential.
The company is leveraging Bitcoin as a performance driver, not just a hedge, reflecting its expanding role in corporate finance. The company’s Bitcoin Dashboard offers transparent, Regulation FD-compliant updates on key metrics, including BTC yield and acquisition costs.
The Rise of Bitcoin in Corporate Treasuries
Semler’s significant Bitcoin holdings signal a bold shift for a healthcare-focused company, as they follow in the footsteps of the American business intelligence firm, Strategy. This move reflects growing institutional demand for performance-driven assets and underscores Bitcoin’s integration into mainstream finance.
The healthcare company’s multi-million BTC holdings make a strong case for Bitcoin in corporate finance, and its dashboard provides real-time performance updates that could influence other companies’ treasury strategies.
Meanwhile, Strategy and the Japanese firm Metaplanet have embarked on a weekly BTC purchase streak, continuing to fill their bags despite market volatility.
